The expanded suite of products, named "Novalis Powered by TrueBeam STx,” is a natural extension of a relationship between the two companies that began in 1996, and grew with their collaboration around the Novalis Tx radiosurgery platform, which was launched in 2007. Novalis Powered by TrueBeam STx will give clinicians radiosurgical and image-guidance capabilities designed for targeted stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments. It will also include Brainlab iPlan treatment planning and ExacTrac room-based X-ray imaging technology, as well as Varian's HD120 MLC multileaf collimator for high resolution beam shaping.
"TrueBeam STx technology will significantly enhance the Varian-Brainlab offering to the radiosurgery market with its significant speed and precision,” said Dow Wilson, president of oncology systems at Varian. "The Novalis Radiosurgery Program includes a comprehensive package of clinical applications, workflow, knowledge base, and training for radiosurgery,”
"Expanding our partnership with Varian to combine TrueBeam STx with the Novalis Radiosurgery Program gives us a stronger and broader platform for innovation in neurosurgery,” said Stefan Vilsmeier, CEO of Brainlab. "We believe the combination of our leading technologies can help make significant clinical advancements in the fight against cancer and other neurological conditions. Our goal is to increase access to advanced treatment.”
The TrueBeam STx system is specially configured for advanced radiosurgery and is designed to deliver treatments up to 50% faster, with a dose delivery rate of up to 2,400 monitor units per minute, double the maximum output of earlier Varian systems. This makes it possible to offer greater patient comfort by shortening treatments, and to improve precision by leaving less time for tumor motion during dose delivery.
Related Links:
Varian Medical Systems
Brainlab
